Finding an encouraging drug lead that selectively engages a target of interest is the result of several critical matches that lead to successful drug discovery programs, including:

• Matching a small molecule library with an innovative assay technology
• Matching a primary screening platform with orthogonal assays to validate hits
• Matching a drug discovery company with a leading CRO

• Access to a collection of over a half million diverse and pharmacophore-like small molecules
• An industry-leading label-free and high-throughput screening technology for biochemical and binding assays
• Comprehensive solutions including assay development, screening, and hit triage with orthogonal assays